Determining asset value and investment levels to inform critical commercialization decisions

IQVIA utilizes proprietary data assets, secondary research and therapeutic expertise to identify analogues meeting your selection criteria. We have designed methodologies for benchmarking, forecasting, and developing P&Ls proven to maximize commercialization success and Net Present Value of your product. IQVIA integrates market sizing, patient flows, and patient longitudinal data to help you assess the product uptake curves and market share.

Contact us and learn more about opportunity assessment.